piribedil has been researched along with Agitation, Psychomotor in 2 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tan, EK | 1 |
| Ratnagopal, P | 1 |
| Han, SY | 1 |
| Wong, MC | 1 |
| Angrist, B | 1 |
| Ain, M | 1 |
| Rotrosen, J | 1 |
| Gershon, S | 1 |
| Halpern, FS | 1 |
| Sachar, EJ | 1 |
1 trial available for piribedil and Agitation, Psychomotor
| Article | Year |
|---|---|
Piribedil and bromocriptine in Parkinson's disease: a single-blind crossover study.
Topics: Administration, Oral; Aged; Antiparkinson Agents; Bromocriptine; Cross-Over Studies; Female; Halluci | 2003 |
1 other study available for piribedil and Agitation, Psychomotor
| Article | Year |
|---|---|
Behavioral and neuroendocrine effects of low dose ET-495: antagonism by haloperidol.
Topics: Adult; Dose-Response Relationship, Drug; Growth Hormone; Haloperidol; Humans; Male; Middle Aged; Nau | 1979 |